TGF-β1 and TGF-βR1 variants are associated with clinical outcomes in smoking-related head and neck cancer patients treated with chemoradiation through modulating microRNA-mediated regulation Zihao NiuPeng SunGuojun Li Research Open access 30 March 2024 Article: 85
IL-2 promotes expansion and intratumoral accumulation of tumor infiltrating dendritic cells in pancreatic cancer Tingting GongXinyang HuangQi Wang Research Open access 30 March 2024 Article: 84
23-Hydroxybetulinic acid attenuates 5-fluorouracil resistance of colorectal cancer by modulating M2 macrophage polarization via STAT6 signaling Zeping FanYaru CuiWenbin Duan Research Open access 30 March 2024 Article: 83
DR30318, a novel tri-specific T cell engager for Claudin 18.2 positive cancers immunotherapy Zhe MaZhenxing ZhouLushan Yu Research Open access 30 March 2024 Article: 82
Characterization of a novel anti-PVRIG antibody with Fc-competent function that exerts strong antitumor effects via NK activation in preclinical models Hongyu XueZhimin ZhangKai Chen Research Open access 30 March 2024 Article: 81
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth Andrew N. WilkinsonRui ChenSherry Y. Wu Research Open access 30 March 2024 Article: 80
Efficacy of immune checkpoint inhibitors differs in various status of carcinoma: a study based on 29 cohorts with 3255 participants Chunlan WuYujun KeXianhe Xie Research Open access 30 March 2024 Article: 79
Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma Yijia HeLingyun LiuLiang Ding Research Open access 30 March 2024 Article: 78
Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity Jennifer W. CaoJessica LakeSteven Dow Research Open access 30 March 2024 Article: 77
PGRN inhibits CD8+T cell recruitment and promotes breast cancer progression by up-regulating ICAM-1 on TAM Ting ZhouHusun QianBianqin Guo Research Open access 30 March 2024 Article: 76
Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer Kaiqi ZhangYuan XuKai Yin Research Open access 27 March 2024 Article: 75
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China Huan YanLianxi SongLiang Zeng Research Open access 07 March 2024 Article: 74
Oct4 activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis Zhuoqiong BianXiaoling WuYidong Wang Research Open access 02 March 2024 Article: 73
A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer Gerald S. FalchookJames ReevesEmerson Lim Research Open access 02 March 2024 Article: 72
Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion Jianguo ZhangYangyi LiConghua Xie Research Open access 02 March 2024 Article: 71
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma Tanguy Y. SeiwertSophie WildsmithAmanda Psyrri Research Open access 02 March 2024 Article: 70
Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data Wenjun LiuXitu LuoHao Liu Research Open access 02 March 2024 Article: 69
Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy Lujun ShenHongtong TanWeijun Fan Research Open access 02 March 2024 Article: 68
Neutrophils seeking new neighbors: radiotherapy affects the cellular framework and the spatial organization in a murine breast cancer model C. M. ReichardtM. Muñoz-BecerraL. E. Muñoz Research Open access 02 March 2024 Article: 67
Integrating molecular subtype and CD8+ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer Bingyu LiKaifeng JinWeijuan Zhang Research Open access 02 March 2024 Article: 66
Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity Jiawei YueHui GuoYumin Wu Research Open access 02 March 2024 Article: 65
Clinical immunotherapy in pancreatic cancer Xiaorong YeYue YuHongdi Ma Review Open access 02 March 2024 Article: 64
Riboflavin-LSD1 axis participates in the in vivo tumor-associated macrophage morphology in human colorectal liver metastases Cristiana SoldaniGiulia De SimoneLaura Brunelli Research Open access 02 March 2024 Article: 63
Mechanism exploration of Zoledronic acid combined with PD-1 in the treatment of hepatocellular carcinoma Xinru FanZijun YanHui Wang Research Open access 02 March 2024 Article: 62
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma Zhengjie DaiXuan LinChen Liu Research Open access 02 March 2024 Article: 61
Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells Narendiran RajasekaranXiaoguang WangSanjay D Khare Research Open access 24 February 2024 Article: 60
Multiplexed analysis of macrophage polarisation in pulmonary metastases of microsatellite stable colorectal cancer Topias KarjulaHanna ElomaaJuha P. Väyrynen Research Open access 22 February 2024 Article: 59
Granzyme B+ B cells detected by single-cell sequencing are associated with prognosis in patients with intrahepatic cholangiocarcinoma following liver transplantation Ji-Qiao ZhuYing ZhuQiang He Research Open access 22 February 2024 Article: 58
Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer Angisha BasnetKaitlyn M. LandrethTracy W. Liu Research Open access 17 February 2024 Article: 57
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization Wenxin XuJialei WengYinghao Shen Research Open access 17 February 2024 Article: 56
Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study Hui-min LianJia-liang WuFang Peng Research Open access 16 February 2024 Article: 55
Retrospective assessment of neoadjuvant camrelizumab combined with induction chemotherapy: efficacy in laryngeal preservation for advanced hypopharyngeal and laryngeal squamous cell carcinoma Jin PengGuangfeng LuoXuekui Liu Research Open access 15 February 2024 Article: 54
Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility M. De SilvaB. C. Y. TseM. P. Molloy Review Open access 14 February 2024 Article: 53
Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy Jianying LiAnjun MaGang Xin Research Open access 13 February 2024 Article: 52
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade Sweta KaranEunkyeong JungNicole F. Steinmetz Research Open access 13 February 2024 Article: 51
Low-intensity pulsed ultrasound activated the anti-tumor immunity by irradiating the spleen of mice in 4 T-1 breast cancer Yi XiaMeijie YangYan Wang Research Open access 13 February 2024 Article: 50
Atovaquone enhances antitumor efficacy of TCR-T therapy by augmentation of ROS-induced ferroptosis in hepatocellular carcinoma Anan ChenZhiwu YuWei Zhu Research Open access 13 February 2024 Article: 49
Targeting monoamine oxidase A: a strategy for inhibiting tumor growth with both immune checkpoint inhibitors and immune modulators Yifan MaHanmu ChenChanghong Shi Review Open access 13 February 2024 Article: 48
Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients Qiaoyun TanRuyun GaoYuankai Shi Research Open access 13 February 2024 Article: 47
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypes Konstantinos NtostoglouSofia D. P. TheodorouChristos Kittas Research Open access 13 February 2024 Article: 46
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cells Kathryn KlineTim LuetkensDjordje Atanackovic Brief Report Open access 13 February 2024 Article: 45
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors John F. HiltonPatrick A. OttDan P. Zandberg Research Open access 13 February 2024 Article: 44
Stimulating T cell responses against patient-derived breast cancer cells with neoantigen peptide-loaded peripheral blood mononuclear cells Natthaporn SueangoenHarald GroveChanitra Thuwajit Research Open access 13 February 2024 Article: 43
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment Toru HanamuraKozue YokoyamaNaoki Niikura Research Open access 13 February 2024 Article: 42
Identification macrophage signatures in prostate cancer by single-cell sequencing and machine learning Zhen KangYu-Xuan ZhaoYong Wei Research Open access 13 February 2024 Article: 41
Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer Jietao MaJun SongChengbo Han Research Open access 10 February 2024 Article: 40
Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer Qin ZhuYukun CaoYu Hu Research Open access 31 January 2024 Article: 39
Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data Takafumi YanagisawaKeiichiro MoriTakahiro Kimura Review Open access 30 January 2024 Article: 38
A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy Yuejun LuoChengming LiuJie He Research Open access 28 January 2024 Article: 37
CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors Jianghua WangXiaoting LiBaiyong Li Research Open access 27 January 2024 Article: 36